Form 8-K - Current report:
SEC Accession No. 0001213900-14-009241
Filing Date
2014-12-31
Accepted
2014-12-31 13:04:11
Documents
2
Period of Report
2014-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k123114_dandritbio.htm 8-K 20205
2 SECURITIES PURCHASE AGREEMENT f8k123114ex10i_dandritbio.htm EX-10.1 138697
  Complete submission text file 0001213900-14-009241.txt   160219
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54478 | Film No.: 141318054
SIC: 2834 Pharmaceutical Preparations